Bustling congress winds down
An event which has been both inspirational and educational, this year's BVNA Congress - now in its 40th year - has championed the role of the veterinary nurse, as well as providing top quality CPD.
Delegates at this year's bustling event have enjoyed a fantastic and varied scientific programme, covering everything from management to research and critical care.
On top of this, the congress has provided the opportunity to catch up with the latest veterinary products on the market, and network with other veterinary nurses and members of the profession in a relaxed but vibrant setting.
A keynote speech by James Yeates, the chief veterinary officer at the RSPCA, underlined the role that nurses have to play in the development of the veterinary profession as a whole.
In particular, he championed the empathy and communication that veterinary nurses can build with clients, making them a valuable asset when it comes to euthanasia discussions and cases of domestic abuse, for example.
Furthermore, this year's congress saw a number of veterinary nurses honoured for their extraordinary contribution to the profession and excellent client care, with Sarah Reed crowned this year's Veterinary Nurse of the Year.
Lectures throughout the three-day event have covered key topical issues, including recognising and dealing with pet obesity, emerging equine diseases, mental health and addictions in the veterinary profession and a talk on the future of the Practice Standards Scheme, given by RCVS vice-president Jacqui Molyneux.
Yet another hugely successful congress was concluded today with the BVNA's annual general meeting (AGM), which saw junior vice-president Kirstie Shield welcomed as incoming president.
Delegates are now starting to filter off to the final lectures of the day and exhibitors will soon begin the process of packing up and heading home. Having gained truly high quality CPD hours over the past three days, it is safe to say that this year's event will remain in the minds of delegates for many months to come.
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
